Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117972732 | 11797273 | 2 | F | 20160818 | 20151203 | 20160831 | EXP | US-APOTEX-2015AP010641 | APOTEX | 0.00 | F | Y | 0.00000 | 20160831 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117972732 | 11797273 | 1 | PS | FENTANYL TRANSDERMAL SYSTEM | FENTANYL | 1 | Transdermal | 75 MG, UNK | 43157 | 77449 | 75 | MG | TRANSDERMAL SYSTEM | ||||||
| 117972732 | 11797273 | 2 | SS | FENTANYL TRANSDERMAL SYSTEM | FENTANYL | 1 | Transdermal | 100 MG, UNK | 77449 | 100 | MG | TRANSDERMAL SYSTEM |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117972732 | 11797273 | 1 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117972732 | 11797273 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117972732 | 11797273 | Hyperhidrosis | |
| 117972732 | 11797273 | Pain | |
| 117972732 | 11797273 | Product adhesion issue | |
| 117972732 | 11797273 | Skin reaction | |
| 117972732 | 11797273 | Withdrawal syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |